REVIEW VARIATION AND TERMINATION Sample Clauses

REVIEW VARIATION AND TERMINATION. 8.1. Variation to the service specification will only be made following consultation with Community Pharmacy Wales.
Sample 1Sample 2Sample 3See All (7)
AutoNDA by SimpleDocs
REVIEW VARIATION AND TERMINATION. The service specification shall be reviewed at least annually. Variation to the service specification, Competency and Training Frameworks and NECAF can only be made with the agreement of the Welsh Government. Variation to the service specification can only be made following consultation with Community Pharmacy Wales. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. Local Health Boards will require the agreement of the relevant Area Planning Board before any notice of withdrawal of the service is served. In the event of such notice the service will be terminated 90 days after that notice is received.
Sample 1Sample 2Sample 3See All (5)
REVIEW VARIATION AND TERMINATION. The service specification shall be reviewed at least annually. Variation to the service specification can only be made following consultation with Community Pharmacy Wales. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice the service will be terminated 90 days after that notice is received.
Sample 1
REVIEW VARIATION AND TERMINATION. The service specification shall be reviewed at least annually. Variation to the service specification, Competency and Training Frameworks and Choose Pharmacy can only be made with the agreement of the Welsh Government and only following consultation with Community Pharmacy Wales. Contractors will be notified of any variations to the service specification in writing. No variation to the specification will be made until 90 days after that notice is received. Providers, as signatories to the SLA, may cease to provide the service by giving notice in writing to the Local Health Board. In the event of such notice the service will be terminated 90 days after that notice is received.
Sample 1
REVIEW VARIATION AND TERMINATION. 6.1. The service pilot specification shall be reviewed in March 2015.
Sample 1
REVIEW VARIATION AND TERMINATION. 14. It has been agreed that this document will be reviewed on an annual basis, or if any one of the signatory authorities requests an amendment. The review should also include the provision for testing the implementation procedure of the agreement.
Sample 1
REVIEW VARIATION AND TERMINATION. 10.1 This agreement will be reviewed as appropriate and may be terminated by either side giving to the other side not less than twelve months notice in writing, during which time both sides will work towards reaching a new agreement.
Sample 1
AutoNDA by SimpleDocs

Related to REVIEW VARIATION AND TERMINATION

  • Modification and Termination No agreement to modify, amend, extend, supersede, terminate, or discharge this Settlement Agreement, or any portion thereof, is valid or enforceable unless it is in writing and signed by all Parties to this Settlement Agreement.

  • Duration and Termination This Agreement shall become effective on July 21, 2015 and shall continue in effect until February 28, 2017, and thereafter, only if such continuance is approved at least annually by a vote of the Board, including the vote of a majority of the directors who are not parties to this Agreement or interested persons of any such party, cast in person, at a meeting called for the purpose of voting such approval. In addition, the question of continuance of this Agreement may be presented to the shareholders of the Portfolio; in such event, such continuance shall be effected only if approved by the affirmative vote of the holders of a majority of the outstanding voting securities of the Portfolio. This Agreement may at any time be terminated without payment of any penalty either by vote of the Board or by vote of the holders of a majority of the outstanding voting securities of the Portfolio, on not more than (60) sixty days’ written notice to the Manager. This Agreement shall automatically terminate in the event of its assignment. This Agreement may be terminated by the Manager after ninety (90) days’ written notice to the Fund. Any notice under this Agreement shall be given in writing, addressed and delivered, or mailed post-paid, to the other party at any office of such party. As used in this Section, the terms “assignment,” “interested persons,” “voting securities,” and a “majority of the outstanding voting securities” shall have the respective meanings set forth in Section 2(a)(4), Section 2(a)(19), Section 2(a)(42) of the 1940 Act and Rule 18f-2 thereunder.

  • Expiration and Termination This Agreement is for one academic year (August 1, 2018 through July 31, 2019) and will automatically renew for the following academic year unless terminated as indicated below by either party.

  • Amendments and Termination This Agreement may be amended or terminated only by a written agreement signed by the Company and the Executive.

  • Term of Agreement and Termination 2.1. This Agreement enters into effect at the time of acceptance of this Agreement.

  • DURATION AND TERMINATION OF AGREEMENT This Agreement shall become effective with respect to each Portfolio on the later of (i) its execution and (ii) the date of the meeting of the Board of Trustees of the Trust, at which meeting this Agreement is approved as described below. The Agreement will continue in effect for a period more than two years from the date of its execution only so long as such continuance is specifically approved at least annually either by the Trustees of the Trust or by a majority of the outstanding voting securities of each of the Portfolios, provided that in either event such continuance shall also be approved by the vote of a majority of the Trustees of the Trust who are not interested persons (as defined in the Investment Company Act) of any party to this Agreement cast in person at a meeting called for the purpose of voting on such approval. Any required shareholder approval of the Agreement or of any continuance of the Agreement shall be effective with respect to any Portfolio if a majority of the outstanding voting securities of the series (as defined in Rule 18f-2(h) under the Investment Company Act) of shares of that Portfolio votes to approve the Agreement or its continuance, notwithstanding that the Agreement or its continuance may not have been approved by a majority of the outstanding voting securities of (a) any other Portfolio affected by the Agreement or (b) all the portfolios of the Trust. If any required shareholder approval of this Agreement or any continuance of the Agreement is not obtained, the Subadviser will continue to act as investment subadviser with respect to such Portfolio pending the required approval of the Agreement or its continuance or of a new contract with the Subadviser or a different adviser or subadviser or other definitive action; provided, that the compensation received by the Subadviser in respect of such Portfolio during such period is in compliance with Rule 15a-4 under the Investment Company Act. This Agreement may be terminated at any time, without the payment of any penalty, by the Trustees of the Trust, by the vote of a majority of the outstanding voting securities of the Trust, or with respect to any Portfolio by the vote of a majority of the outstanding voting securities of such Portfolio, on sixty days' written notice to the Adviser and the Subadviser, or by the Adviser or Subadviser on sixty days' written notice to the Trust and the other party. This Agreement will automatically terminate, without the payment of any penalty, in the event of its assignment (as defined in the Investment Company Act) or in the event the Advisory Agreement between the Adviser and the Trust terminates for any reason.

Time is Money Join Law Insider Premium to draft better contracts faster.